Agios Pharmaceuticals | AGIO - Lngresos Netos





Lngresos Netos Cambio Fecha
AbbVie USD 695M 1.12B 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
Astellas Pharma JPY 43.52B 56.86B 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Exelixis USD 210.47M 34.06M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03